Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An arteriovenous shunt is an anatomical or surgically created conduit that connects an artery directly to a vein, bypassing the capillary network. It can be congenital, pathological (e.g., vascular malformations), or iatrogenic (intentionally created for purposes such as haemodialysis vascular access). AV shunts can strongly influence cardiac output and systemic hemodynamics, and may contribute to clinical problems including high-output cardiac failure, volume overload, and vascular complications. AV shunts are classified based on their location (such as peripheral or spinal), type (fistula, graft, or malformation), and clinical indication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arteriovenous shunt (AV shunt).